Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosis-Reference-Cited by-同舟云学术

Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosis

Published:1984-06 Issue:6 Volume:41 Page:863-871
ISSN:0015-0282
Container-title:Fertility and Sterility
language:en
Short-container-title:Fertility and Sterility

Author:

Lemay André,Maheux Rodolphe,Faure Nacia,Jean Clément,Fazekas Atilla T.A.

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Reproductive Medicine

Reference24 articles.

1. Inhibition of ovulation in women by intranasal treatment with a luteinizing hormone-releasing hormone agonist;Bergquist;Contraception,1979

2. Influence of the LH-RH analogue buserelin on cyclic ovarian function and on endometrium: a new approach to fertility control?;Schmidt-Gollwitzer;Contraception,1981

3. Long-term intranasal luteinizing hormone-releasing hormone agonist treatment for contraception in women;Bergquist;Fertil Steril,1982

4. Gonadotroph and corpus luteum responses to two successive intranasal doses of a luteinizing hormone-releasing hormone agonist at different days after the midcycle luteinizing hormone surge;Lemay;Fertil Steril,1983

5. Gonadotropin release during repeated administration of D-Leu6Des-Gly210-LH-RH-EA at different stages of the menstrual cycle and in functional amenorrhea;Hanker;Int J Fertil,1980

Cited by 182 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hormonal Therapies before in vitro fertilization in women with endometriosis: The Minotaur's Labyrinth and the Ariadne's Thread;Best Practice & Research Clinical Obstetrics & Gynaecology;2024-07

2. Reproductive endocrinology;Comprehensive Gynecology;2022

3. Neue Behandlungsoptionen mit GnRH-Antagonisten bei Endometriose und Uterus myomatosus;Gynäkologische Endokrinologie;2020-08-07

4. Neue Behandlungsmöglichkeiten der Endometriose mit GnRH-Antagonisten;Der Gynäkologe;2020-07-08

5. GnRH-Antagonisten in der Behandlung des Uterus myomatosus;Der Gynäkologe;2020-07-07